Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)

Reem Elkeky, MBBS, David A. Jacobsohn, MD, Rajni Agarwal, MD, Swati Naik, MBBS, Neena Kapoor, MD, Lakshmanan Krishnamurti, MD, Mary Slatter, MD, Federica Galaverna, MD, Pietro Merli, MD, Melissa Aldinger, PharmD, Franco Locatelli

Blood (2018) 132 (Supplement 1): 2207.

https://doi.org/10.1182/blood-2018-99-119792

Published: 2018

Journal Articles

Outcome of Children with Primary Immune-Deficiencies (PIDs) Enrolled in a Phase I-II Trial Based on the Infusion of BPX-501 Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) after T-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (haplo-HSCT)

Neena Kapoor, MD, Alice Bertaina, MD PhD, Pietro Merli, MD, Swati Naik, MD, Waseem Qasim, MBBS PhD, Mary Slatter, MD, Reem Elfeky, MD, Barbarella Lucarelli, MD, Monika Smogorzewska, PhD, Giuseppina Li Pira, PhD, Valentina Bertaina, PhD, Annemarie Moseley, MD PhD, Franco Locatelli, MD

Blood (2016) 128 (22): 72.

https://doi.org/10.1182/blood.V128.22.72.72

Published: 2016

Journal Articles

Long Term Humoral Immune Reconstitution Kinetics After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Children

Amro Elshoury, MD, Neena Kapoor, MD, Ami J Shah, MD, Bhakti Mehta, MD, Kris M. Mahadeo, MD, Hisham Abdel-Azim, MD

Blood (2013) 122 (21): 4627.

https://doi.org/10.1182/blood.V122.21.4627.4627

Published: 2013

Journal Articles

Improved Outcomes After Reduced Intensity Conditioning Matched Unrelated Donor Hematopoietic Stem Cell Transplantation In Children With Chronic Granulomatous Disease

Bhakti Mehta, MD, Kris M. Mahadeo, MD, Ami J Shah, MD, Neena Kapoor, MD, Hisham Abdel-Azim, MD

Blood (2013) 122 (21): 2272.

https://doi.org/10.1182/blood.V122.21.2272.2272

Published: 2013

Journal Articles

Impact of Thymic Function On Chronic Graft-Versus-Host Disease (cGVHD).

Kris M. Mahadeo, M.D., M.P.H., Ami J Shah, MD, Bernadette Masinsin, BS, Neena Kapoor, MD, Hisham Abdel-Azim, MD, Robertson Parkman, M.D.

Blood (2012) 120 (21): 3052.

https://doi.org/10.1182/blood.V120.21.3052.3052

Published: 2012

Journal Articles

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

Ann M. Leen, PhD, Catherine M. Bollard, MD, Adam M. Mendizabal, MS, Elizabeth J. Shpall, MD, Paul Szabolcs, MD, Joseph H. Antin, MD, Neena Kapoor, MD, Sung-Yun Pai, MD, Scott D. Rowley, MD, Partow Kebriaei, M.D., Bambi J. Grilley, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2012) 120 (21): 457.

https://doi.org/10.1182/blood.V120.21.457.457

Published: 2012

Journal Articles

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Michael J Eckrich, MD, MPH, Jennifer Le-Rademacher, PhD, J. Douglas Rizzo, MD, MS, K. Scott Baker, MD, MS, Deepika Bhatla, MD, David K. Buchbinder, M.D., M.S.H.S., Kenneth R. Cooke, MD, Reggie Duerst, MD, Andrew Gilman, MD, Haydar Frangoul, MD, Neena Kapoor, MD, Nancy A. Kernan, MD, Michael Verneris, MD, Mary Eapen, MBBS

Blood (2012) 120 (21): 762.

https://doi.org/10.1182/blood.V120.21.762.762

Published: 2012

Journal Articles

Chronic Graft-Versus-Host Disease and Systemic Sclerosis: The Same Pathophysiology?,

Robertson Parkman, MD, Ami J Shah, MD, Bernadette Masinsin, BS, Neena Kapoor, MD, Hisham Abdel-Azim, MD, Andreas Reiff, MD

Blood (2011) 118 (21): 4076.

https://doi.org/10.1182/blood.V118.21.4076.4076

Published: 2011

Journal Articles

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

Ann M. Leen, PhD, Catherine M Bollard, MD, Adam M Mendizabal, Elizabeth J. Shpall, MD, Paul Szabolcs, MD, Joseph H. Antin, MD, Neena Kapoor, MD, Callie Heaton, Bambi J Grilley, Adrian P. Gee, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Cliona M Rooney, PhD, Helen E. Heslop, MD

Blood (2010) 116 (21): 829.

https://doi.org/10.1182/blood.V116.21.829.829

Published: 2010

Journal Articles

Campath 1H Versus ATG for the Prophylaxis of Graft Versus Host Disease Does Not Increase the Risk of Relapse or Infections.

Ami J. Shah, MD, Neena Kapoor, MD, Gay M. Crooks, MD, Donald B. Kohn, MD, Kenneth I. Weinberg, MD, Renna Killen, RN, Lily Kuo, Robertson Parkman, MD

Blood (2006) 108 (11): 2888.

https://doi.org/10.1182/blood.V108.11.2888.2888

Published: 2006

Journal Articles

Unrelated Donor Hematopoietic Cell Transplant (HCT) for Hemophagocytic Lymphohistiocytosis (HLH).

K. Scott Baker, MD, Mary Eapen, MBBS, Thomas Gross, MD, Gregory A. Hale, MD, Robert Hayashi, MD, Naynesh R. Kamani, MD, Neena Kapoor, MD, Alexandra Filipovich, MD

Blood (2006) 108 (11): 174.

https://doi.org/10.1182/blood.V108.11.174.174

Published: 2006

Journal Articles

Defective Anti-Bacterial Carbohydrate Antibody Production after Unrelated HSC Transplantation.

Ami J. Shah, MD, John E. Wagner, MD, Neena Kapoor, MD, Raymond Chan, Kenneth I. Weinberg, MD, Robertson Parkman, MD

Blood (2004) 104 (11): 5060.

https://doi.org/10.1182/blood.V104.11.5060.5060

Published: 2004

NARROW

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)

Long Term Humoral Immune Reconstitution Kinetics After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Children

Improved Outcomes After Reduced Intensity Conditioning Matched Unrelated Donor Hematopoietic Stem Cell Transplantation In Children With Chronic Granulomatous Disease

Impact of Thymic Function On Chronic Graft-Versus-Host Disease (cGVHD).

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Chronic Graft-Versus-Host Disease and Systemic Sclerosis: The Same Pathophysiology?,

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

Campath 1H Versus ATG for the Prophylaxis of Graft Versus Host Disease Does Not Increase the Risk of Relapse or Infections.

Unrelated Donor Hematopoietic Cell Transplant (HCT) for Hemophagocytic Lymphohistiocytosis (HLH).

Defective Anti-Bacterial Carbohydrate Antibody Production after Unrelated HSC Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only